Published in J Anat on June 01, 2002
Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med (2006) 3.72
Narrative review: the systemic capillary leak syndrome. Ann Intern Med (2010) 3.71
Reactive oxygen species in inflammation and tissue injury. Antioxid Redox Signal (2013) 2.59
Thin-walled microvessels in human coronary atherosclerotic plaques show incomplete endothelial junctions relevance of compromised structural integrity for intraplaque microvascular leakage. J Am Coll Cardiol (2009) 2.26
Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity. J Exp Med (2010) 2.23
HIV-1 gp120 compromises blood-brain barrier integrity and enhances monocyte migration across blood-brain barrier: implication for viral neuropathogenesis. J Cereb Blood Flow Metab (2006) 1.72
Protein kinase involved in lung injury susceptibility: evidence from enzyme isoform genetic knockout and in vivo inhibitor treatment. Proc Natl Acad Sci U S A (2003) 1.62
Brain endothelial cell-cell junctions: how to "open" the blood brain barrier. Curr Neuropharmacol (2008) 1.38
Myosin light chain kinase in microvascular endothelial barrier function. Cardiovasc Res (2010) 1.37
Role of Epac1, an exchange factor for Rap GTPases, in endothelial microtubule dynamics and barrier function. Mol Biol Cell (2008) 1.34
Endothelial signaling in paracellular and transcellular leukocyte transmigration. Front Biosci (Landmark Ed) (2009) 1.31
Role of reactive oxygen and nitrogen species in the vascular responses to inflammation. Free Radic Biol Med (2011) 1.17
ICAM-1-mediated endothelial nitric oxide synthase activation via calcium and AMP-activated protein kinase is required for transendothelial lymphocyte migration. Mol Biol Cell (2008) 1.11
Perturbation of endothelial junction proteins by Staphylococcus aureus alpha-toxin: inhibition of endothelial gap formation by adrenomedullin. Histochem Cell Biol (2006) 1.11
Peptide Bbeta(15-42) preserves endothelial barrier function in shock. PLoS One (2009) 1.02
Air bubble contact with endothelial cells in vitro induces calcium influx and IP3-dependent release of calcium stores. Am J Physiol Cell Physiol (2011) 0.96
Identification and characterization of Dlc1 isoforms in the mouse and study of the biological function of a single gene trapped isoform. BMC Biol (2010) 0.94
The tyrosine phosphatase SHP2 regulates recovery of endothelial adherens junctions through control of β-catenin phosphorylation. Mol Biol Cell (2012) 0.94
The role of repulsive guidance molecules in the embryonic and adult vertebrate central nervous system. Philos Trans R Soc Lond B Biol Sci (2006) 0.92
Vascular endothelial growth factor-C, a potential paracrine regulator of glomerular permeability, increases glomerular endothelial cell monolayer integrity and intracellular calcium. Am J Pathol (2008) 0.90
The phenotype of the human materno-fetal endothelial barrier: molecular occupancy of paracellular junctions dictate permeability and angiogenic plasticity. J Anat (2002) 0.90
Genome Wide Identification of SARS-CoV Susceptibility Loci Using the Collaborative Cross. PLoS Genet (2015) 0.84
Involvement of the H1 Histamine Receptor, p38 MAP Kinase, Myosin Light Chains Kinase, and Rho/ROCK in Histamine-Induced Endothelial Barrier Dysfunction. Microcirculation (2015) 0.82
Surface Plasmon Resonance Monitoring of Cell Monolayer Integrity: Implication of Signaling Pathways Involved in Actin-Driven Morphological Remodeling. Cell Mol Bioeng (2008) 0.80
Effect of H1- and H2-histamine receptor blockade on postexercise insulin sensitivity. Physiol Rep (2013) 0.80
Anthrax lethal toxin-induced gene expression changes in mouse lung. Toxins (Basel) (2011) 0.79
Small Rho GTPase-mediated actin dynamics at endothelial adherens junctions. Small GTPases (2016) 0.75
Microvascular transport and tumor cell adhesion in the microcirculation. Ann Biomed Eng (2012) 0.75
Histamine Induces Alzheimer's Disease-Like Blood Brain Barrier Breach and Local Cellular Responses in Mouse Brain Organotypic Cultures. Biomed Res Int (2015) 0.75
Rho GTPases and the actin cytoskeleton. Science (1998) 28.19
Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase) Science (1996) 15.88
Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature (1997) 14.91
Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol (1995) 10.61
Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem (1996) 10.51
Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol (2000) 5.94
Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol (2000) 5.24
Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. J Clin Invest (2001) 5.05
Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci (1995) 4.83
Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases. Mol Pharmacol (2000) 4.80
Microvascular permeability. Physiol Rev (1999) 4.12
Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat Med (2001) 3.69
Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. Proc Natl Acad Sci U S A (1999) 3.49
Phosphorylation of myosin-binding subunit (MBS) of myosin phosphatase by Rho-kinase in vivo. J Cell Biol (1999) 3.43
Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr Top Microbiol Immunol (1999) 3.42
Regulation of endothelial cell gap formation and barrier dysfunction: role of myosin light chain phosphorylation. J Cell Physiol (1995) 2.80
Vascular endothelial growth factor induces endothelial fenestrations in vitro. J Cell Biol (1998) 2.71
Activation of RhoA by thrombin in endothelial hyperpermeability: role of Rho kinase and protein tyrosine kinases. Circ Res (2000) 2.26
Phosphorylation of adducin by Rho-kinase plays a crucial role in cell motility. J Cell Biol (1999) 2.17
Phosphorylation of non-muscle myosin II regulatory light chain by p21-activated kinase (gamma-PAK). J Muscle Res Cell Motil (1998) 2.14
Thrombin inactivates myosin light chain phosphatase via Rho and its target Rho kinase in human endothelial cells. J Biol Chem (1998) 2.02
Myosin light chain kinase-regulated endothelial cell contraction: the relationship between isometric tension, actin polymerization, and myosin phosphorylation. J Cell Biol (1995) 1.98
Cofilin phosphorylation and actin cytoskeletal dynamics regulated by rho- and Cdc42-activated LIM-kinase 2. J Cell Biol (1999) 1.96
Rho-kinase--mediated contraction of isolated stress fibers. J Cell Biol (2001) 1.92
Cofilin phosphorylation by protein kinase testicular protein kinase 1 and its role in integrin-mediated actin reorganization and focal adhesion formation. Mol Biol Cell (2001) 1.88
Protein kinase C-alpha signals rho-guanine nucleotide dissociation inhibitor phosphorylation and rho activation and regulates the endothelial cell barrier function. J Biol Chem (2001) 1.82
Histamine induces tyrosine phosphorylation of endothelial cell-to-cell adherens junctions. Arterioscler Thromb Vasc Biol (1999) 1.81
Thrombin-induced increase in endothelial permeability is associated with changes in cell-to-cell junction organization. Arterioscler Thromb Vasc Biol (1996) 1.78
Transient and prolonged increase in endothelial permeability induced by histamine and thrombin: role of protein kinases, calcium, and RhoA. Circ Res (1998) 1.74
Role of RhoA and Rho kinase in lysophosphatidic acid-induced endothelial barrier dysfunction. Arterioscler Thromb Vasc Biol (2000) 1.66
Regulation of tight junction permeability and occludin phosphorylation by Rhoa-p160ROCK-dependent and -independent mechanisms. J Biol Chem (2001) 1.57
SHP2 association with VE-cadherin complexes in human endothelial cells is regulated by thrombin. J Biol Chem (2000) 1.56
Role of cyclic adenosine monophosphate in the induction of endothelial barrier properties. J Cell Physiol (1989) 1.55
Pretreatment with inhaled nitric oxide inhibits neutrophil migration and oxidative activity resulting in attenuated sepsis-induced acute lung injury. Crit Care Med (1997) 1.54
Platelet lipid(s) bound to albumin increases endothelial electrical resistance: mimicked by LPA. Am J Physiol Lung Cell Mol Physiol (2001) 1.53
Endothelial gaps: time course of formation and closure in inflamed venules of rats. Am J Physiol (1997) 1.50
Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm. Cardiovasc Res (1999) 1.48
Phosphorylation of myosin light chain kinase by p21-activated kinase PAK2. J Biol Chem (2000) 1.45
Induction of endothelial cell chemotaxis by sphingosine 1-phosphate and stabilization of endothelial monolayer barrier function by lysophosphatidic acid, potential mediators of hematopoietic angiogenesis. J Hematother Stem Cell Res (1999) 1.43
Histamine increases venular permeability via a phospholipase C-NO synthase-guanylate cyclase cascade. Am J Physiol (1993) 1.41
Simvastatin inhibits leukocyte-endothelial cell interactions and protects against inflammatory processes in normocholesterolemic rats. Arterioscler Thromb Vasc Biol (1999) 1.39
Increased endothelial albumin permeability mediated by protein kinase C activation. J Clin Invest (1990) 1.39
Rho as a mediator of G protein-coupled receptor signaling. Mol Pharmacol (1999) 1.38
Pathways of macromolecular extravasation across microvascular endothelium in response to VPF/VEGF and other vasoactive mediators. Microcirculation (1999) 1.38
Extracellular matrix, junctional integrity and matrix metalloproteinase interactions in endothelial permeability regulation. J Anat (2002) 1.37
Regulation of endothelial cell gap formation and paracellular permeability. J Investig Med (1995) 1.36
Simvastatin exerts both anti-inflammatory and cardioprotective effects in apolipoprotein E-deficient mice. Circulation (2001) 1.34
cGMP and nitric oxide modulate thrombin-induced endothelial permeability. Regulation via different pathways in human aortic and umbilical vein endothelial cells. Circ Res (1995) 1.33
Regulation of microvascular permeability by vascular endothelial growth factors. J Anat (2002) 1.30
Plasmalemmal vesicles represent the large pore system of continuous microvascular endothelium. Am J Physiol (1993) 1.29
Modulation of venular microvessel permeability by calcium influx into endothelial cells. FASEB J (1992) 1.29
Norepinephrine and iloprost improve barrier function of human endothelial cell monolayers: role of cAMP. Am J Physiol (1991) 1.28
Regulation of endothelial cell myosin light chain kinase by Rho, cortactin, and p60(src). Am J Physiol (1999) 1.26
Tumor necrosis factor mediates experimental pulmonary edema by ICAM-1 and CD18-dependent mechanisms. J Clin Invest (1992) 1.26
Openings in frog microvascular endothelium induced by high intravascular pressures. J Physiol (1996) 1.24
Nitric oxide-cyclic GMP signal transduction system. Methods Enzymol (1996) 1.23
Microvascular permeability and number of tight junctions are modulated by cAMP. Am J Physiol (1998) 1.23
Nitric oxide signaling: would you believe that a simple free radical could be a second messenger, autacoid, paracrine substance, neurotransmitter, and hormone? Recent Prog Horm Res (1998) 1.23
Histamine and thrombin modulate endothelial focal adhesion through centripetal and centrifugal forces. J Clin Invest (1996) 1.22
Cytoskeletal effects of rho-like small guanine nucleotide-binding proteins in the vascular system. Arterioscler Thromb Vasc Biol (2001) 1.21
The beta 2-adrenergic receptor agonist formoterol reduces microvascular leakage by inhibiting endothelial gap formation. Am J Physiol (1994) 1.20
ROCK mediates thrombin's endothelial barrier dysfunction. Am J Physiol Cell Physiol (2000) 1.20
Lysophosphatidic acid increases tight junction permeability in cultured brain endothelial cells. J Neurochem (1997) 1.19
Regulation of cytosolic guanylyl cyclase by nitric oxide: the NO-cyclic GMP signal transduction system. Adv Pharmacol (1994) 1.18
RhoA inactivation enhances endothelial barrier function. Am J Physiol (1999) 1.18
Polymorphonuclear leukocyte-dependent plasma leakage in the rabbit skin is enhanced or inhibited by prostacyclin, depending on the route of administration. Am J Pathol (1986) 1.15
Control of systemic capillary leak syndrome with aminophylline and terbutaline. Am J Med (1992) 1.13
The role of cytokines and adhesion molecules in the development of inflammatory injury. Mol Med Today (1995) 1.10
Vascular endothelial adhesion molecules and tissue inflammation. Pharmacol Rev (1996) 1.10
Expression of cGMP-dependent protein kinase I and phosphorylation of its substrate, vasodilator-stimulated phosphoprotein, in human endothelial cells of different origin. Circ Res (1995) 1.10
Vascular endothelial growth factor and microvascular permeability. Microcirculation (1999) 1.09
Capillary leakage in inflammation. A study by vascular labeling. Am J Pathol (1990) 1.08
Simvastatin improves disturbed endothelial barrier function. Circulation (2000) 1.06
Roles of calcium, cyclic nucleotides, and protein kinase C in regulation of endothelial permeability. Arteriosclerosis (1990) 1.03
Differential actions of cAMP on endothelial [Ca2+]i and permeability in microvessels exposed to ATP. Am J Physiol (1993) 1.02
cAMP protects endothelial barrier function independent of inhibiting MLC20-dependent tension development. Am J Physiol (1998) 1.01
Characterization of an in vitro model to study the permeability of human arterial endothelial cell monolayers. Thromb Haemost (1988) 1.00
Nitric oxide attenuates lung endothelial injury caused by sublethal hyperoxia in rats. Am J Physiol (1997) 1.00
Role of ICAM-1 in neutrophil-mediated lung vascular injury after occlusion and reperfusion. Am J Physiol (1991) 1.00
Openings through endothelial cells associated with increased microvascular permeability. Microcirculation (1999) 1.00
Role of phosphodiesterases in the regulation of endothelial permeability in vitro. J Clin Invest (1993) 1.00
Endothelial permeability for macromolecules. Mechanistic aspects of pathophysiological modulation. Arterioscler Thromb Vasc Biol (1997) 0.99
VEGF stimulates tyrosine phosphorylation of beta-catenin and small-pore endothelial barrier dysfunction. Am J Physiol (1999) 0.97
Effects of isoprenaline and cooling on histamine induced changes of capillary permeability in the rat hindquarter vascular bed. Acta Physiol Scand (1978) 0.96
Protein kinase C phosphorylates caldesmon77 and vimentin and enhances albumin permeability across cultured bovine pulmonary artery endothelial cell monolayers. J Cell Physiol (1992) 0.96
The effect of histamine and cyclic adenosine monophosphate on myosin light chain phosphorylation in human umbilical vein endothelial cells. J Clin Invest (1993) 0.96
High-dose atrial natriuretic factor enhances albumin escape from the systemic but not the pulmonary circulation. Circ Res (1990) 0.95
Cyclic-GMP-mediated decrease in permeability of human umbilical and pulmonary artery endothelial cell monolayers. J Vasc Res (1994) 0.93
Location of focal silver staining at endothelial gaps in inflamed venules examined by scanning electron microscopy. Am J Physiol (1995) 0.92
Atrial natriuretic peptide inhibits oxidant-induced increases in endothelial permeability. J Mol Cell Cardiol (1991) 0.90
Opposing roles of cyclic AMP in the vascular control of edema formation. FASEB J (1993) 0.89
Capillary hydraulic conductivity is elevated by cGMP-dependent vasodilators. Circ Res (1992) 0.87
Thrombin-induced lung vascular injury. Roles of fibrinogen and fibrinolysis. Am Rev Respir Dis (1983) 0.86
Role of nitric oxide and phosphodiesterase isoenzyme II for reduction of endothelial hyperpermeability. Am J Physiol (1996) 0.86
Effects of inhaled nitric oxide or inhibition of endogenous nitric oxide formation on hyperoxic lung injury. Am J Respir Crit Care Med (1997) 0.86
Macromolecular transport across arterial and venous endothelium in rats. Studies with Evans blue-albumin and horseradish peroxidase. Arteriosclerosis (1990) 0.86
Atriopeptin inhibition of thrombin-mediated changes in the morphology and permeability of endothelial monolayers. Proc Natl Acad Sci U S A (1989) 0.86
Functional antagonism between cAMP and cGMP on permeability of coronary endothelial monolayers. Am J Physiol (1996) 0.84
Simvastatin, capillary permeability, and acetylcholine-mediated vasomotion in atherosclerotic, hypercholesterolemic men. Clin Pharmacol Ther (2000) 0.84
Mechanisms of thrombin-induced lung vascular injury and edema. Am Rev Respir Dis (1987) 0.84
Predictors of pulmonary edema formation during fluid loading in the critically ill with presumed hypovolemia*. Crit Care Med (2012) 3.66
Reversal of vascular leak with imatinib. Am J Respir Crit Care Med (2013) 2.01
Vascular endothelial growth factor overexpression in ischemic skeletal muscle enhances myoglobin expression in vivo. Circ Res (2004) 1.93
Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia. Crit Care Med (2009) 1.87
Effective treatment of edema and endothelial barrier dysfunction with imatinib. Circulation (2012) 1.70
Driving Rho GTPase activity in endothelial cells regulates barrier integrity. Thromb Haemost (2009) 1.67
Localized RhoA GTPase activity regulates dynamics of endothelial monolayer integrity. Cardiovasc Res (2013) 1.63
Plasma protein levels are markers of pulmonary vascular permeability and degree of lung injury in critically ill patients with or at risk for acute lung injury/acute respiratory distress syndrome. Crit Care Med (2011) 1.60
Substrate stiffening promotes endothelial monolayer disruption through enhanced physical forces. Am J Physiol Cell Physiol (2010) 1.53
Microtubule-targeting agents inhibit angiogenesis at subtoxic concentrations, a process associated with inhibition of Rac1 and Cdc42 activity and changes in the endothelial cytoskeleton. Mol Cancer Ther (2006) 1.36
Circulating angiopoietin-2 levels in the course of septic shock: relation with fluid balance, pulmonary dysfunction and mortality. Intensive Care Med (2009) 1.16
Nitric oxide-dependent Src activation and resultant caveolin-1 phosphorylation promote eNOS/caveolin-1 binding and eNOS inhibition. Mol Biol Cell (2012) 1.16
KLF2-induced actin shear fibers control both alignment to flow and JNK signaling in vascular endothelium. Blood (2009) 1.08
The angiopoietin-Tie2 system as a therapeutic target in sepsis and acute lung injury. Expert Opin Ther Targets (2009) 1.05
Physiological concentrations of insulin induce endothelin-dependent vasoconstriction of skeletal muscle resistance arteries in the presence of tumor necrosis factor-alpha dependence on c-Jun N-terminal kinase. Arterioscler Thromb Vasc Biol (2005) 1.04
Plasma biomarkers for acute respiratory distress syndrome: a systematic review and meta-analysis*. Crit Care Med (2014) 1.03
Vasoconstrictor effects of insulin in skeletal muscle arterioles are mediated by ERK1/2 activation in endothelium. Am J Physiol Heart Circ Physiol (2004) 1.03
Direct grafting of RGD-motif-containing peptide on the surface of polycaprolactone films. J Biomater Sci Polym Ed (2006) 1.02
Activation of AMP-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside in the muscle microcirculation increases nitric oxide synthesis and microvascular perfusion. Arterioscler Thromb Vasc Biol (2010) 0.99
Endothelin receptor blockade combined with phosphodiesterase-5 inhibition increases right ventricular mitochondrial capacity in pulmonary arterial hypertension. Am J Physiol Heart Circ Physiol (2009) 0.95
Nuclear targeting of beta-catenin and p120ctn during thrombin-induced endothelial barrier dysfunction. Cardiovasc Res (2008) 0.95
The interaction of soluble Tie2 with angiopoietins and pulmonary vascular permeability in septic and nonseptic critically ill patients. Shock (2010) 0.94
Rho-kinase-dependent F-actin rearrangement is involved in the inhibition of PI3-kinase/Akt during ischemia-reperfusion-induced endothelial cell apoptosis. Apoptosis (2008) 0.93
Inhibition of Rho-ROCK signaling induces apoptotic and non-apoptotic PS exposure in cardiomyocytes via inhibition of flippase. J Mol Cell Cardiol (2010) 0.91
Opposing effects of the angiopoietins on the thrombin-induced permeability of human pulmonary microvascular endothelial cells. PLoS One (2011) 0.89
Role of protein kinase Czeta in thrombin-induced RhoA activation and inter-endothelial gap formation of human dermal microvessel endothelial cell monolayers. Microvasc Res (2010) 0.87
Interference with actin dynamics is superior to disturbance of microtubule function in the inhibition of human ovarian cancer cell motility. Biochem Pharmacol (2008) 0.86
Successful treatment of diffuse pulmonary lymphangiomatosis with bevacizumab. Ann Intern Med (2012) 0.84
Endogenous RhoA inhibitor protects endothelial barrier. Circ Res (2007) 0.82
Role of ROCK I/II in vascular branching. Am J Physiol Heart Circ Physiol (2009) 0.81
Endothelial hyperpermeability in vascular leakage. Vascul Pharmacol (2002) 0.79
Rac1 as a Potential Pharmacodynamic Biomarker for Thiopurine Therapy in Inflammatory Bowel Disease. Ther Drug Monit (2016) 0.78
Smooth muscle F-actin disassembly and RhoA/Rho-kinase signaling during endotoxin-induced alterations in pulmonary arterial compliance. Am J Physiol Lung Cell Mol Physiol (2003) 0.77
RhoA-ROCK signaling is involved in contraction-mediated inhibition of SERCA2a expression in cardiomyocytes. Pflugers Arch (2009) 0.77
Fibrin β15-42 domain is cryptic in intact fibrinogen: comment on the study by A. Sahni et al. Int J Cancer (2010) 0.77
Rac1 functions as a reversible tension modulator to stabilize VE-cadherin trans-interaction. J Cell Biol (2015) 0.76
Activated protein C in the treatment of acute lung injury and acute respiratory distress syndrome. Expert Opin Drug Discov (2009) 0.76